Merck announces $70 billion US manufacturing investment

Published



EXCLUSIVE — Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical company announced on Monday.

The company officially kicked off its planned domestic investment by breaking ground on a $3 billion pharmaceutical manufacturing site in Elkton, Virginia on Monday morning. The new site will employ over 500 full-time workers and create about 8,000 construction jobs within Virginia.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.